Parenteral Drugs (India) Ltd.
| BSE: 524689 | Sector: Health care |
| NSE: PDPL | ISIN Code: INE904D01019 |
| BSE 14:22 | 28 Jun | 4.67 |
0.22 (4.94%) |
OPEN
4.67 |
HIGH
4.67 |
LOW
4.67 |
| NSE 13:57 | 28 Jun | 4.25 |
0.20 (4.94%) |
OPEN
4.25 |
HIGH
4.25 |
LOW
4.25 |
| OPEN | 4.67 |
| PREVIOUS CLOSE | 4.45 |
| VOLUME | 1202 |
| 52-Week high | 5.87 |
| 52-Week low | 2.51 |
| P/E | |
| Mkt Cap.(Rs cr) | 14 |
| Buy Price | 4.67 |
| Buy Qty | 42106.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Parenteral Drugs (India) Ltd. (PDPL) - Announcements
-
Parenteral Drugs (India) Ltd Disclosures Of Related Party Transactions On Consolidated Basis For Half Year Ended On 31-03-2022.
14/06/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
31/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Results-Financial Results For The Quarter And Year Ended 31St March 2022
30/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2022.
30/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
28/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Board Meeting Intimation for Consideration Of The Annual Audited Financial Results For The Fourth Qu
18/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliance - Compliance Certificate Under Regulation 40(10) Of SEBI (LODR) Regulations 2015
13/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances - Compliance Certificate For The Period Ended 31St March 2022
13/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/05/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
26/04/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement Under Regulation 30 SEBI (LODR) - Updates (OTS)
28/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Intimation Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regul
01/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Submission Of Scrutinizer Report Of Extra Ordinary General Meeting Held On 1St March 2022.
01/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Disclosure Of E- Voting Results Along With Scrutinizer Report
01/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
01/03/2022 | bse
-
Parenteral Drugs (India) Ltd Extra Ordinary General Meeting - 01St March 2022
01/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement Under Regulation 30 (LODR) - Summary Proceedings Of Extra-Ordinary General Meeting Held
01/03/2022 | bse |
Downlaod PDF -
Parenteral Drugs (India) Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/02/2022 | bse |
Downlaod PDF
Quick Links for Parenteral Drugs (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
